We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

101 hedge funds and large institutions have $20.5M invested in Definium Therapeutics in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more call options, than puts

Call options by funds: $20.9M | Put options by funds: $6.14M

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

37% more capital invested

Capital invested by funds: $14.9M → $20.5M (+$5.59M)

19.01% more ownership

Funds ownership: 0.36% → 19.37% (+19%)

0% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 34

35% less funds holding

Funds holding: 155 → 101 (-54)

75% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 72

Holders
101
Holders Change
-54
Holders Change %
-34.84%
% of All Funds
1.74%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
18
Increased
34
Reduced
34
Closed
72
Calls
$20.9M
Puts
$6.14M
Net Calls
+$14.7M
Net Calls Change
+$13.7M

Top Buyers

1
DCI
Data Collective IV
California
+$13.5M
2
MFG
Merit Financial Group
Georgia
+$10M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$9.6M
4
CH
CVI Holdings
Delaware
+$6.26M
5
EAM
Empery Asset Management
New York
+$1.8M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$1.76M
2
E
Ergoteles
New York
-$696K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$405K
4
LPL Financial
LPL Financial
California
-$324K
5
PCM
Penserra Capital Management
California
-$282K
Name Holding Trade Value Shares
Change 		Change in
Stake
AF
151
Allworth Financial
California
– +$144 +15 +22%
HWMA
152
Heritage Wealth Management (Arizona)
Arizona
– +$182 +19 New
RF
153
Robbins Farley
New Hampshire
– +$269 +28 New
FCA
154
FinTrust Capital Advisors
South Carolina
– +$317 +33 New
HS
155
Horan Securities
United States
– +$317 +33 +1,650%
GI
156
Gradient Investments
Minnesota
– +$374 +39 +3,900%
BC
157
Burleson & Co
California
– +$816 +85 +98%
BWL
158
Bogart Wealth LLC
Virginia
– +$960 +100 New
3 4 5 6
7

DFTX Hedge Fund Activity: Q3 2022 in Review

101 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q3 2022, worth a combined $20.5M — up 37% from $14.9M a quarter earlier.

Sellers outnumbered buyers: 72 funds closed out of DFTX and 18 opened new positions — a net loss of 54 holders — while 34 trimmed existing stakes and 34 added.

The largest buyer was Data Collective IV, adding an estimated $13.5M. The largest seller was Millennium Management, cutting an estimated $1.76M.

  • 101 institutional investors held Definium Therapeutics (DFTX) as of Q3 2022, down from 155 in Q2 2022.
  • Funds reported $20.5M of Definium Therapeutics stock for Q3 2022, up 37% quarter-over-quarter.
  • 18 funds opened new Definium Therapeutics positions in Q3 2022 and 72 closed out, a net change of -54 holders.
  • The largest Definium Therapeutics buyer in Q3 2022 was Data Collective IV, an estimated $13.5M added.
  • The largest Definium Therapeutics seller in Q3 2022 was Millennium Management, an estimated $1.76M sold.

Based on aggregated 13F filings for Q3 2022.